Nrf2 expression and activity in human T lymphocytes: Stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone

Free Radical Biology and Medicine

Volumn 71, Issue , 2014, Pages 133-145

  Morzadec, Claudie ^a   Macoch, Mélinda ^a   Sparfel, Lydie ^a   Kerdine Römer, Saadia ^b   Fardel, Olivier ^a,c   Vernhet, Laurent ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Universite Paris Sud   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Antioxidant genes; Arsenic; Cytokines; Free radicals; Nrf2; T lymphocytes

Indexed keywords

2-TERT-BUTYLHYDROQUINONE; ARSENIC; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; HISTONE ACETYLTRANSFERASE PCAF; HYDROQUINONE DERIVATIVE; INTERLEUKIN 17; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; NFE2L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; PROTEIN TRANSPORT; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; ARSENIC; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; HYDROQUINONES; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NF-E2-RELATED FACTOR 2; P300-CBP TRANSCRIPTION FACTORS; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898910640     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.03.006     Document Type: Article

References (41)

1. Q. Ma Role of nrf2 in oxidative stress and toxicity Annu. Rev. Pharmacol. Toxicol. 53 2013 401 426
2. J.W. Kaspar, S.K. Niture, and A.K. Jaiswal Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radic Biol. Med. 47 2009 1304 1309
3. R. Brigelius-Flohe, and L. Flohe Basic principles and emerging concepts in the redox control of transcription factors Antioxid. Redox Signaling 15 2011 2335 2381
4. Y. Katoh, K. Itoh, E. Yoshida, M. Miyagishi, A. Fukamizu, and M. Yamamoto Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription Genes Cells 6 2001 857 868
5. M. Komatsu, H. Kurokawa, S. Waguri, K. Taguchi, A. Kobayashi, Y. Ichimura, Y.S. Sou, I. Ueno, A. Sakamoto, K.I. Tong, M. Kim, Y. Nishito, S. Iemura, T. Natsume, T. Ueno, E. Kominami, H. Motohashi, K. Tanaka, and M. Yamamoto The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 Nat. Cell Biol. 12 2010 213 223
6. J. Kim, Y.N. Cha, and Y.J. Surh A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders Mutat. Res. 690 2010 12 23
7. R.K. Thimmulappa, H. Lee, T. Rangasamy, S.P. Reddy, M. Yamamoto, T.W. Kensler, and S. Biswal Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis J. Clin. Invest. 116 2006 984 995
8. A.K. Ruotsalainen, M. Inkala, M.E. Partanen, J.P. Lappalainen, E. Kansanen, P.I. Makinen, S.E. Heinonen, H.M. Laitinen, J. Heikkila, T. Vatanen, S. Horkko, M. Yamamoto, S. Yla-Herttuala, M. Jauhiainen, and A.L. Levonen The absence of macrophage Nrf2 promotes early atherogenesis Cardiovasc. Res. 98 2013 107 115
9. T. Rangasamy, C.Y. Cho, R.K. Thimmulappa, L. Zhen, S.S. Srisuma, T.W. Kensler, M. Yamamoto, I. Petrache, R.M. Tuder, and S. Biswal Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice J. Clin. Invest. 114 2004 1248 1259
10. D. Malhotra, R.K. Thimmulappa, N. Mercado, K. Ito, P. Kombairaju, S. Kumar, J. Ma, D. Feller-Kopman, R. Wise, P. Barnes, and S. Biswal Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients J. Clin. Invest. 121 2011 4289 4302
11. T. Rangasamy, J. Guo, W.A. Mitzner, J. Roman, A. Singh, A.D. Fryer, M. Yamamoto, T.W. Kensler, R.M. Tuder, S.N. Georas, and S. Biswal Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice J. Exp. Med. 202 2005 47 59
12. Z. El Ali, C. Gerbeix, P. Hemon, P.R. Esser, S.F. Martin, M. Pallardy, and S. Kerdine- Romer Allergic skin inflammation induced by chemical sensitizers is controlled by the transcription factor Nrf2 Toxicol. Sci. 134 2013 39 48
13. D.A. Johnson, S. Amirahmadi, C. Ward, Z. Fabry, and J.A. Johnson The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis Toxicol. Sci. 114 2010 237 246
14. X. Kong, R. Thimmulappa, F. Craciun, C. Harvey, A. Singh, P. Kombairaju, S.P. Reddy, D. Remick, and S. Biswal Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis Am. J. Respir. Crit. Care Med. 184 2011 928 938
15. Q. Ma, L. Battelli, and A.F. Hubbs Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2 Am. J. Pathol. 168 2006 1960 1974
16. C.E. Rockwell, M. Zhang, P.E. Fields, and C.D. Klaassen Th2 skewing by activation of Nrf2 in CD4(+) T cells J. Immunol. 188 2012 1630 1637
17. K.A. Frauwirth, and C.B. Thompson Activation and inhibition of lymphocytes by costimulation J. Clin. Invest. 109 2002 295 299
18. A.E. Schade, G.L. Schieven, R. Townsend, A.M. Jankowska, V. Susulic, R. Zhang, H. Szpurka, and J.P. Maciejewski Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation Blood 111 2008 1366 1377
19. C. Morzadec, F. Bouezzedine, M. Macoch, O. Fardel, and L. Vernhet Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes Toxicology 300 2012 46 56
20. C. Morzadec, M. Macoch, M. Robineau, L. Sparfel, O. Fardel, and L. Vernhet Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes Toxicol. Appl. Pharmacol. 262 2012 217 222
21. M. Pizon, H. Rampanarivo, S. Tauzin, B. Chaigne-Delalande, S. Daburon, M. Castroviejo, P. Moreau, J.F. Moreau, and P. Legembre Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosis Eur. J. Immunol. 41 2011 2368 2378
22. S. Lee, M.J. Lim, M.H. Kim, C.H. Yu, Y.S. Yun, J. Ahn, and J.Y. Song An effective strategy for increasing the radiosensitivity of human lung cancer cells by blocking Nrf2-dependent antioxidant responses Free Radic. Biol. Med. 53 2012 807 816
23. A. Lau, W. Tian, S.A. Whitman, and D.D. Zhang The predicted molecular weight of Nrf2: it is what it is not Antioxid. Redox Signaling 18 2013 91 93
24. L. Davis, and P.E. Lipsky Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes J. Immunol. 136 1986 3588 3596
25. S.A. Rushworth, L. Zaitseva, M.Y. Murray, N.M. Shah, K.M. Bowles, and D.J. MacEwan The high Nrf2 expression in human acute myeloid leukemia is driven by NF-kappaB and underlies its chemo-resistance Blood 120 2012 5188 5198
26. L.P. Kane, J. Lin, and A. Weiss It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation Trends Immunol. 23 2002 413 420
27. S.A. Park, H.K. Na, E.H. Kim, Y.N. Cha, and Y.J. Surh 4-Hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species Cancer Res. 69 2009 2416 2424
28. G. Sanchez-Duffhues, M.A. Calzado, A.G. de Vinuesa, G. Appendino, B.L. Fiebich, U. Loock, A. Lefarth-Risse, K. Krohn, and E. Munoz Denbinobin inhibits nuclear factor-kappaB and induces apoptosis via reactive oxygen species generation in human leukemic cells Biochem. Pharmacol. 77 2009 1401 1409
29. M.D. Carretta, P. Alarcon, E. Jara, L. Solis, J.L. Hancke, I.I. Concha, M.A. Hidalgo, and R.A. Burgos Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation Eur. J. Pharmacol. 602 2009 413 421
30. S.C. Lu Glutathione synthesis Biochim. Biophys. Acta 1830 2013 3143 3153
31. R. Roozendaal, H.F. Kauffman, A.J. Dijkhuis, E.T. Ommen, D.S. Postma, J.G. de Monchy, and E. Vellenga Interaction between nitric oxide and subsets of human T lymphocytes with differences in glutathione metabolism Immunology 107 2002 334 339
32. Y. Abiko, T. Miura, B.H. Phuc, Y. Shinkai, and Y. Kumagai Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole Toxicol. Appl. Pharmacol. 255 2011 32 39
33. N. Ade, F. Leon, M. Pallardy, J.L. Peiffer, S. Kerdine-Romer, M.H. Tissier, P.A. Bonnet, I. Fabre, and J.C. Ourlin HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway Toxicol. Sci. 107 2009 451 460
34. A. Lemarie, C. Morzadec, D. Merino, O. Micheau, O. Fardel, and L. Vernhet Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation J. Pharmacol. Exp. Ther. 316 2006 304 314
35. M. Macoch, C. Morzadec, O. Fardel, and L. Vernhet Inorganic arsenic impairs differentiation and functions of human dendritic cells Toxicol. Appl. Pharmacol. 266 2013 204 213
36. X. He, and Q. Ma NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation Mol. Pharmacol. 76 2009 1265 1278
37. X.J. Wang, Z. Sun, W. Chen, Y. Li, N.F. Villeneuve, and D.D. Zhang Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction Toxicol. Appl. Pharmacol. 230 2008 383 389
38. A. Lau, Y. Zheng, S. Tao, H. Wang, S.A. Whitman, E. White, and D.D. Zhang Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner Mol. Cell. Biol. 33 2013 2436 2446
39. Z. Sun, Y.E. Chin, and D.D. Zhang Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response Mol. Cell. Biol. 29 2009 2658 2672
40. M. Shale, C. Schiering, and F. Powrie CD4(+) T-cell subsets in intestinal inflammation Immunol. Rev. 252 2013 164 182
41. K. Hirahara, A. Poholek, G. Vahedi, A. Laurence, Y. Kanno, J.D. Milner, and J.J. O'Shea Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease J. Allergy Clin. Immunol. 131 2013 1276 1287